Brokers Set Expectations for Organigram Q1 Earnings

Organigram Holdings Inc. (TSE:OGIFree Report) – Equities research analysts at Atb Cap Markets issued their Q1 2025 EPS estimates for Organigram in a note issued to investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

Several other brokerages have also weighed in on OGI. Canaccord Genuity Group cut their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research report on Monday, December 9th. ATB Capital dropped their price target on Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th.

View Our Latest Analysis on OGI

Organigram Stock Performance

TSE:OGI opened at C$2.22 on Monday. Organigram has a fifty-two week low of C$1.61 and a fifty-two week high of C$3.95. The firm’s 50 day moving average is C$2.26 and its two-hundred day moving average is C$2.30. The company has a market cap of C$241.03 million, a P/E ratio of -0.88, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.13.

Insider Transactions at Organigram

In other news, Senior Officer Paolo De Luca sold 12,014 shares of the company’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. Company insiders own 31.32% of the company’s stock.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Further Reading

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.